|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7012 USD | +2.36% |
|
-24.02% | -48.06% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||
Pharmaceuticals | - | - | - | - | 19.19M | |||
Total Assets | - | - | - | - | 10.42M | |||
CAPEX | - | - | - | - | -184K | |||
EBT | - | - | - | - | -2.04M | |||
Gross Profit | - | - | - | - | 11.97M | |||
D&A | - | - | - | - | 1.8M | |||
Operating Income | - | - | - | - | -2.16M | |||
Net Income | - | - | - | - | -2.04M |
Geographical Revenue Distribution History
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
United States | 44.48M | 35.4M | 24.16M | 19.48M | 19.19M | |||
Total Assets | 125M | 40.79M | 16.2M | 10.58M | 10.42M | |||
Interest Expense | -28.93K | 16.25K | - | -29.51K | - | |||
Income Tax Expense | -895K | - | - | - | - | |||
D&A | 2.25M | 2.97M | 2.93M | 1.82M | 1.8M | |||
CAPEX | -342K | -689K | -298K | -190K | -184K | |||
Gross Profit | 29.99M | 22.34M | 14.98M | 12M | 11.97M | |||
Net Income | -23.39M | -70.08M | -22.94M | -3.7M | -2.04M | |||
EBT | -24.29M | -70.08M | -22.94M | -3.7M | -2.04M | |||
Operating Income | -19.62M | -78.27M | -22.49M | -3.32M | -2.16M |
- Stock Market
- Equities
- YCBD Stock
- Financials cbdMD, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
